The way weve just accepted weight gain as an inevitable consequence of antipsychotic medications
Drugmaker Eli Lilly (LLY -2.39%) hasn't been exempt from the recent market pullback, but its stock shot higher following the announcement that its newest GLP-1 drug had successfully completed the first of several phase 3 drug trials
If you're experiencing side effects on either medication that are making you think of switching, talk with your clinician
CrossRef The efficacy and safety of novel antidiabetic agents in polycystic ovary syndrome: a network meta-analysis Junjie Lin, Rongtao Yang, Jiacheng Zhuang, Wenbo Zhang, Qiang Tong, Jiahui Liu, Ye Kang, Yuan Yuan Journal of Ovarian Research.2026;[Epub] CrossRef Hypothalamus-liver talks: whispers in the language of metabolism Vitor Ferreira, Iara Fernndez-Gonzlez, Jane Jose Vattathara, Amanda Rodrguez-Daz, Paola Fernndez-Sanmartn, Carlos Diguez Reviews in Endocrine and Metabolic Disorders.2026